Volume 14, Issue 2, Pages 141-145 (February 2014) MSC-Based Product Characterization for Clinical Trials: An FDA Perspective Michael Mendicino, Alexander M. Bailey, Keith Wonnacott, Raj K. Puri, Steven R. Bauer Cell Stem Cell Volume 14, Issue 2, Pages 141-145 (February 2014) DOI: 10.1016/j.stem.2014.01.013 Copyright © 2014 Elsevier Inc. Terms and Conditions
Figure 1 The Tissue Source for MSC-Based Product INDs Has Become Diverse over Time Data from original IND submissions were compiled (n = 66). The percentage of bone-marrow-derived MSC-based product INDs is displayed per year. Cell Stem Cell 2014 14, 141-145DOI: (10.1016/j.stem.2014.01.013) Copyright © 2014 Elsevier Inc. Terms and Conditions